FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 119 filers reported holding FATE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,079 | -55.5% | 14,660 | 0.0% | 0.00% | – |
Q2 2023 | $69,782 | -16.5% | 14,660 | 0.0% | 0.00% | – |
Q1 2023 | $83,562 | -43.5% | 14,660 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $147,919 | -34.0% | 14,660 | +47.0% | 0.00% | 0.0% |
Q3 2022 | $224,000 | -9.3% | 9,975 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $247,000 | -36.2% | 9,975 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $387,000 | -50.5% | 9,975 | -25.3% | 0.00% | -50.0% |
Q4 2021 | $782,000 | +60.6% | 13,360 | +62.4% | 0.00% | +33.3% |
Q3 2021 | $487,000 | -31.9% | 8,225 | -0.2% | 0.00% | -25.0% |
Q2 2021 | $715,000 | +5.6% | 8,238 | +0.4% | 0.00% | 0.0% |
Q1 2021 | $677,000 | -21.6% | 8,206 | -13.6% | 0.00% | -20.0% |
Q4 2020 | $864,000 | +211.9% | 9,497 | +37.2% | 0.01% | +150.0% |
Q3 2020 | $277,000 | +16.4% | 6,924 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $238,000 | +107.0% | 6,924 | +33.7% | 0.00% | +100.0% |
Q1 2020 | $115,000 | +101.8% | 5,179 | +76.5% | 0.00% | – |
Q4 2019 | $57,000 | +23.9% | 2,934 | 0.0% | 0.00% | – |
Q3 2019 | $46,000 | -23.3% | 2,934 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $60,000 | +15.4% | 2,934 | 0.0% | 0.00% | – |
Q1 2019 | $52,000 | +4.0% | 2,934 | -24.1% | 0.00% | -100.0% |
Q4 2018 | $50,000 | +28.2% | 3,865 | +61.0% | 0.00% | – |
Q3 2018 | $39,000 | – | 2,401 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $11,083,330 | 2.77% |
Redmile Group, LLC | 13,169,057 | $43,194,507 | 2.61% |
SUPERSTRING CAPITAL MANAGEMENT LP | 497,360 | $1,631,341 | 2.06% |
Boxer Capital, LLC | 8,215,910 | $26,948,185 | 1.42% |
Deep Track Capital, LP | 5,572,607 | $18,278,151 | 0.55% |
Vestal Point Capital, LP | 2,000,000 | $6,560,000 | 0.49% |
Bruce & Co., Inc. | 300,000 | $984,000 | 0.32% |
Octagon Capital Advisors LP | 520,800 | $1,708,224 | 0.27% |
Integral Health Asset Management, LLC | 850,000 | $2,788,000 | 0.26% |
Bellevue Group AG | 4,839,779 | $15,874,475 | 0.26% |